CTU A PHASE 2 OPEN-LABEL STUDY OF SACITUZUMAB GOVITECAN (IMMU-132) IN SUBJECTS WITH METASTATIC SOLID TUMORS

  • Zhang, Alison (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Chester, Catherine (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleIMMU-132-11
AcronymIMMU-132-11
StatusActive
Effective start/end date7/07/22 → 15/06/27